Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany – results of a database analysis from May 2010 to April 2012-Reference-Cited by-同舟云学术

Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany – results of a database analysis from May 2010 to April 2012

Published:2015-06-21 Issue:1 Volume:15 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Ehlken Birgit,Anastassopoulou Anastassia,Hain Johannes,Schröder Claudia,Wahle Klaus

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/article/10.1186/s12889-015-1885-0/fulltext.html

Reference38 articles.

1. World Health Organization (WHO). Influenza (Seasonal). Fact sheet N°211. March 2014 [ http://www.who.int/mediacentre/factsheets/fs211/en/index.html , Access: 03.12.2014].

2. Lai PL. Burden of the 1999–2008 seasonal influenza epidemics in Italy - comparison with the H1N1v (A/California/07/09) pandemic. Hum Vaccin. 2011;7(Suppl):217–25.

3. Szucs T, Behrens M, Volmer T. Volkswirtschaftliche Kosten der Influenza 1996. Eine Krankheitskostenstudie. Med Klin. 2001;96:63–70.

4. Karve S, Misurski D, Herrera-Taracena G, Davis KL. Annual all-cause healthcare costs among influenza patients with and without influenza-related complications: analysis of a United States managed care database. Appl Health Econ Health Policy. 2013;11:119–28.

5. Levy E. French economic evaluations of influenza and influenza vaccination. Pharmacoeconomics. 1996;9 Suppl 3:62–6.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds;GMS HYG INFECT CONTR;2024

2. Zellkulturbasierte Influenzaimpfstoffe: eine effektive Impfstoffoption für unter 60-Jährige;Wiener klinische Wochenschrift;2024-02

3. Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model;PharmacoEconomics;2023-07-11

4. Platelet count and risk of severe illness in hospitalised children with Influenza‐Like illness;Acta Paediatrica;2023-06-21

5. Weiterentwickelte zielgruppenorientierte Influenzaimpfstoffe – Neue Evidenz zeigt höhere Effektivität bei älteren Erwachsenen;DMW - Deutsche Medizinische Wochenschrift;2023-03-29